The Enterprise Value as of April 2026 (TTM) for Genmab A/S (GMAB) is 20.12B

According to Genmab A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 20.12B. This represents a change of -79.63% compared to the average of 98.74B of the last 4 quarters.

Genmab A/S (GMAB) Historical Enterprise Value (quarterly & annually)

How has GMAB Enterprise Value performed in the past?

The mean historical Enterprise Value of Genmab A/S over the last ten years is 112.92B. The current 20.12B Enterprise Value has changed 1.68% with respect to the historical average. Over the past ten years (40 quarters), GMAB's Enterprise Value was at its highest in in the December 2022 quarter at 182.96B. The Enterprise Value was at its lowest in in the March 2016 quarter at 54.41B.

Genmab A/S (GMAB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Genmab A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genmab A/S (GMAB) Average Enterprise Value

How has GMAB Enterprise Value performed in the past?

The current Enterprise Value of Genmab A/S (GMAB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Genmab A/S (GMAB) Enterprise Value vs. Peers

How is GMAB’s Enterprise Value compared to its peers?

Genmab A/S’s Enterprise Value is greater than Incyte Corporation (16.12B), less than United Therapeutics Corporation (23.53B), less than Royalty Pharma plc (29.59B), less than Tenet Healthcare Corporation (25.23B), less than Illumina, Inc. (20.31B), less than Quest Diagnostics Incorporated (27.98B), greater than Roivant Sciences Ltd. (19.10B), greater than Summit Therapeutics Inc. (16.86B), less than Zimmer Biomet Holdings, Inc. (22.94B), greater than Exelixis, Inc. (11.03B),

Build a custom stock screener for Genmab A/S (GMAB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genmab A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genmab A/S (GMAB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genmab A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.